(Q70049878)

English

Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial

scientific article published on 01 January 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

author name string

F Porzsolt

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

D Messerer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

R Hautmann

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

A Gottwald

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

H Sparwasser

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

K Stockamp

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

W Aulitzky

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J G Moormann

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

K Schumacher

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

H Rasche

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1988

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

114

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

95-100

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00390492

0 references

Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Spontaneous remission of metastases from renal cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons in the treatment of malignant melanoma. A review of recent trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon therapy for the treatment of renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of renal cell carcinoma with human leukocyte alpha-interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of the tumor, nodes and metastasis classification of renal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discrepant effects of interferon on murine syngeneic ascites tumors and their solid metastastzing counterparts

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noncycling Tumor Cells Are Sensitive Targets for the Antiproliferative Activity of Human Interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of metastatic renal cell carcinoma: a computer analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human lymphoblastoid interferon therapy for advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon and doxorubicin in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon therapy in disseminated renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma: antitumor effects of leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Role of Adjunctive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proceedings: Cancer of the kidney--natural history and staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon in the treatment of malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha interferon for induction of remission in hairy-cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic options in renal-cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status of the therapy of advanced renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal therapy and chemotherapy of renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha therapy of renal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2965154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00390492

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2965154%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70049878&oldid=1899112540"